Skip to content

Clinical trials

Terminated Liver Cirrhosis, Biliary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Status: Terminated Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20111
20141
20151
20161
20171
20183
20192
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals4
Gilead Sciences2
Arena Pharmaceuticals1
Cara Therapeutics, Inc.1
Duke University1
Eli Lilly and Company1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
University of Nebraska1
Washington University School of Medicine1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary14
Fibrosis3
Cholangitis, Sclerosing2
Liver Diseases2
Liver Diseases, Alcoholic2
Pruritus2
Digestive System Diseases1
Fatigue1
Hepatitis, Autoimmune1
Liver Failure1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.